ONCODES.PREC.MED. EO-34 Net Asset Momentum
ONCODES.PREC.MED. EO-34 net asset momentum. ONCODES.PREC.MED. EO-34 (ZR8) recorded a net asset momentum of -111.6% as of December 2024, with net assets of €-429.39K EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ONCODES.PREC.MED. EO-34 (2021–2024)
Net asset momentum of ONCODES.PREC.MED. EO-34 from 2021 to 2024. This chart tracks ONCODES.PREC.MED. EO-34's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is -111.6%, with net assets of €-429.39K EUR as of December 2024. See net assets of ONCODES.PREC.MED. EO-34 for net asset value and shareholders' equity analysis.
ONCODES.PREC.MED. EO-34 Net Asset Momentum by Year (2021–2024)
ONCODES.PREC.MED. EO-34 net asset momentum by year from 2021 to 2024. The table below shows the complete annual net asset history for ONCODES.PREC.MED. EO-34 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ONCODES.PREC.MED. EO-34 (ZR8) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €-429.39K | €10.71 Million | €11.14 Million | ▼ -111.6% |
| 2023 | €3.69 Million | €16.63 Million | €12.94 Million | ▼ -68.7% |
| 2022 | €11.78 Million | €18.37 Million | €6.59 Million | ▲ +180.5% |
| 2021 | €4.20 Million | €8.37 Million | €4.17 Million | — |